Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-25-000010
Filing Date
2025-01-30
Accepted
2025-01-30 06:29:53
Documents
1
Period of Report
2025-01-30

Document Format Files

Seq Description Document Type Size
1 6-K form6k-5_013025.htm 6-K 41700
  Complete submission text file 0001395064-25-000010.txt   42706
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 25571073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)